Hashimoto's Thyroiditis Affects Symptom Load and Quality of Life Unrelated to Hypothyroidism: a Prospective Case-control Study in Women Undergoing Thyroidectomy for Benign Goiter
Overview
Authors
Affiliations
Background: Hashimoto's thyroiditis (HT) is a common disease, and is the most prevalent cause of hypothyroidism. Symptoms and diseases associated with HT are considered to be caused by hypothyroidism. We hypothesized that higher antithyroperoxidase (anti-TPO) antibody levels would be associated with an increased symptom load and a decreased quality of life in a female euthyroid patient collective.
Methods: In a prospective cohort study 426 consecutive euthyroid female patients undergoing thyroid surgery for benign thyroid disease were included. Main outcome measures were preoperative anti-TPO levels, a symptom questionnaire and the SF-36 questionnaire, and lymphocytic infiltration of the thyroid tissue as evaluated by histology.
Results: Histology revealed HT in 28/426 (6.6%) subjects. To maximize the sum of the predictive values, a cut-off point for anti-TPO of 121.0 IU/mL was calculated (sensitivity 93.3% [95% confidence interval: 77.9%-99.0%]; specificity 94.7% [95% confidence interval: 92.0%-96.7%]) to predict the presence of histological signs of HT. The mean number of reported symptoms was significantly higher in patients with anti-TPO levels >121.0 IU/mL than in the other group (6.7 ± 2.5 vs. 4.1 ± 2.8; p < 0.001). There were no differences in preoperative thyroid-stimulating hormone levels (1.7 ± 1.3 vs. 1.5 ± 1.4 μU/mL, respectively; p = 0.155). Chronic fatigue, dry hair, chronic irritability, chronic nervousness, a history of breast cancer and early miscarriage, and lower quality-of-life levels were significantly associated with anti-TPO levels exceeding the cut-off point (p < 0.05).
Conclusions: Women with HT suffer from a high symptom load. Hypothyroidism is only a contributing factor to the development of associated conditions.
Metabolomics-based treatment for chronic diseases: results from a multidisciplinary clinical study.
Tsoukalas D, Sarandi E, Fragoulakis V, Xenidis S, Mhliopoulou M, Charta M BMJ Nutr Prev Health. 2025; 7(2):e000883.
PMID: 39882279 PMC: 11773651. DOI: 10.1136/bmjnph-2024-000883.
Li J, Huang Q, Sun S, Zhou K, Wang X, Pan K Sci Rep. 2024; 14(1):27902.
PMID: 39537841 PMC: 11561229. DOI: 10.1038/s41598-024-78938-7.
Stempler M, Bakos B, Solymosi T, Kiss A, Armos R, Szili B Heliyon. 2024; 10(20):e39639.
PMID: 39502224 PMC: 11535356. DOI: 10.1016/j.heliyon.2024.e39639.
Huang Q, Pan K, Zhang Y, Li S, Li J Asia Pac J Clin Nutr. 2024; 33(3):397-404.
PMID: 38965727 PMC: 11397562. DOI: 10.6133/apjcn.202409_33(3).0010.
Tabakoglu N, Celik M J Clin Med. 2024; 13(11).
PMID: 38892793 PMC: 11173285. DOI: 10.3390/jcm13113082.